<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05094323</url>
  </required_header>
  <id_info>
    <org_study_id>10 2021</org_study_id>
    <nct_id>NCT05094323</nct_id>
  </id_info>
  <brief_title>Analgesia After Video-Assisted Thoracic Surgery</brief_title>
  <official_title>Analgesic Efficacy of Ultrasound-Guided Deep Serratus Anterior Plane Block, Local Wound Infiltration, and Thoracic Paravertebral Block After Uniportal Video-Assisted Thoracic Surgery: A Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although less invasive, postoperative analgesia remains challenging in patients undergoing&#xD;
      uniportal video-assisted thoracic surgery (VATS).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Although less invasive, postoperative analgesia remains challenging in patients undergoing&#xD;
      uniportal video-assisted thoracic surgery (VATS).&#xD;
&#xD;
      Adequate postoperative pain relief is imperative to hasten functional recovery, accelerate&#xD;
      discharge from the hospital, and reduce chronic postsurgical pain.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2022</start_date>
  <completion_date type="Anticipated">January 2023</completion_date>
  <primary_completion_date type="Anticipated">January 2023</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to first analgesic requirement</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>Assessed in minutes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain intensity</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>Assessed by the numerical rating pain scale, an 11-point scale graded from 0 to 10 (0 = no pain, 10 = the worst imaginable pain)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">102</enrollment>
  <condition>Post Operative Pain</condition>
  <arm_group>
    <arm_group_label>Group I</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive ultrasound-guided deep serratus anterior plane block.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive local wound infiltration (LWI).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group III</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive ultrasound-guided thoracic paravertebral block.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ultrasound-guided deep serratus anterior plane block with isobaric bupivacaine</intervention_name>
    <description>Patients will receive ultrasound-guided deep serratus anterior plane block with isobaric bupivacaine.</description>
    <arm_group_label>Group I</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Local wound infiltration with isobaric bupivacaine</intervention_name>
    <description>Patients will receive local wound infiltration with isobaric bupivacaine.</description>
    <arm_group_label>Group II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ultrasound-guided thoracic paravertebral block with isobaric bupivacaine</intervention_name>
    <description>Patients will receive ultrasound-guided thoracic paravertebral block with isobaric bupivacaine.</description>
    <arm_group_label>Group III</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients scheduled for uniportal VATS under general anesthesia, ASA status I-III, aged&#xD;
             from 18 to 70 years old of both sex.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindications to regional block&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Body mass index (BMI) &gt; 30 Kg/m2&#xD;
&#xD;
          -  Psychiatric diseases&#xD;
&#xD;
          -  Severe renal, liver, or cardiac dysfunction&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Seham M Moeen, MD</last_name>
    <phone>01006386324</phone>
    <phone_ext>02</phone_ext>
    <email>seham.moeen@aun.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ahmed K Fathy, Msc</last_name>
    <phone>01098774731</phone>
    <phone_ext>02</phone_ext>
    <email>Ahmedkhaledf@yahoo.com</email>
  </overall_contact_backup>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 14, 2021</study_first_submitted>
  <study_first_submitted_qc>October 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 26, 2021</study_first_posted>
  <last_update_submitted>November 1, 2021</last_update_submitted>
  <last_update_submitted_qc>November 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Seham Mohamed Moeen Ibrahim</investigator_full_name>
    <investigator_title>Assistant professor of Anesthesia and Intensive Care</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

